1. Home
  2. CERO vs GXAI Comparison

CERO vs GXAI Comparison

Compare CERO & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERO
  • GXAI
  • Stock Information
  • Founded
  • CERO 2017
  • GXAI 2021
  • Country
  • CERO United States
  • GXAI United States
  • Employees
  • CERO N/A
  • GXAI N/A
  • Industry
  • CERO
  • GXAI
  • Sector
  • CERO
  • GXAI
  • Exchange
  • CERO Nasdaq
  • GXAI Nasdaq
  • Market Cap
  • CERO 8.4M
  • GXAI 7.5M
  • IPO Year
  • CERO N/A
  • GXAI 2023
  • Fundamental
  • Price
  • CERO $2.34
  • GXAI $2.00
  • Analyst Decision
  • CERO
  • GXAI
  • Analyst Count
  • CERO 0
  • GXAI 0
  • Target Price
  • CERO N/A
  • GXAI N/A
  • AVG Volume (30 Days)
  • CERO 80.5M
  • GXAI 2.3M
  • Earning Date
  • CERO 02-20-2025
  • GXAI 11-14-2024
  • Dividend Yield
  • CERO N/A
  • GXAI N/A
  • EPS Growth
  • CERO N/A
  • GXAI N/A
  • EPS
  • CERO N/A
  • GXAI N/A
  • Revenue
  • CERO N/A
  • GXAI $2,979.00
  • Revenue This Year
  • CERO N/A
  • GXAI N/A
  • Revenue Next Year
  • CERO N/A
  • GXAI N/A
  • P/E Ratio
  • CERO N/A
  • GXAI N/A
  • Revenue Growth
  • CERO N/A
  • GXAI N/A
  • 52 Week Low
  • CERO $2.22
  • GXAI $1.01
  • 52 Week High
  • CERO $1,280.00
  • GXAI $19.20
  • Technical
  • Relative Strength Index (RSI)
  • CERO 32.54
  • GXAI 44.91
  • Support Level
  • CERO $2.83
  • GXAI $1.62
  • Resistance Level
  • CERO $3.50
  • GXAI $2.03
  • Average True Range (ATR)
  • CERO 1.13
  • GXAI 0.36
  • MACD
  • CERO 0.05
  • GXAI -0.13
  • Stochastic Oscillator
  • CERO 1.43
  • GXAI 20.54

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

About GXAI Gaxos.ai Inc.

Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.

Share on Social Networks: